The CCAAT-binding transcription factor NF-Y plays a central role in regulating cellular proliferation by controlling the expression of genes required for cell-cycle progression such as cyclin A, cyclin B1, cyclin B2, cdc25A, cdc25C, and cdk1. Here we show that unrestricted NF-Y activity leads to apoptosis in an E2F1-and wild-type p53 (wtp53)-dependent manner. Unrestricted NF-Y activity induced an increase in E2F1 mRNA and protein levels. Furthermore, NF-Y directly bound the E2F1 promoter and this correlated with the appearance of open chromatin marks. The ability of NF-Y to induce apoptosis was impaired in cells lacking E2F1 and wtp53. Moreover, NF-Y overexpression elicited phosphorylation of wt p53Ser18 in an E2F1-dependent manner. Our findings establish that NF-Y acts upstream of E2F1 in p53-mediated apoptosis.
Introduction
NF-Y is a ubiquitous protein, composed of 3 subunits, NF-YA, -YB, and -YC, whose genes are highly conserved from yeast to mammals. All 3 subunits are required for NF-Y binding to the consensus sequence, the CCAAT-box. The NF-YB and -YC subunits contain histone-like domains, and an activation domain is present in the NF-YA subunit (1) . A bioinformatic analysis of promoters of cell-cycle regulatory genes shows an abundance of CCAAT boxes in promoters regulated during the G 2 /M transition (2) . Consistent with this, the NF-Y complex supports basal transcription of a class of regulatory genes responsible for cell-cycle progression, among which are mitotic cyclin complexes (3) (4) (5) (6) (7) (8) (9) .
NF-YA is the regulatory subunit of the trimer. Indeed, expression of the protein is modulated during the cell cycle (3) and its abrogation plays an important role in downregulating several cell-cycle control genes in differentiated muscle cells (5) (6) (7) 10) . Recently, it has been shown that NF-Y regulates gene expression in embryonic stem cells, where it is required for their proliferation (11) . Previous studies aimed at understanding the biological role of NF-Y took advantage of a loss of function approach, such as expression of dominant-negative NF-YA mutants and conditional deletion of the mouse NF-YA gene. When a dominant-negative NF-YA mutant that interacts with -YB/YC but does not bind DNA is expressed in mouse fibroblasts, retardation of cell growth is observed (12) . Moreover, inactivation of the NF-YA gene in mouse embryonic fibroblasts results in inhibition of cell proliferation and growth arrest at various phases of the cell cycle (13) . Taken together, these studies demonstrated that the binding of NF-Y to cellular promoters is essential for cell proliferation.
Numerous findings indicate that NF-Y is involved in cancer. We have demonstrated that NF-Y modulates the promoter activity of several genes in response to DNA-damaging agents (14, 15) . Next, we have shown that NF-Y interacts in vivo with mutant p53 and increases DNA synthesis, which is impaired upon abrogation of NF-YA expression (4) . Clinical studies have indicated that patients with upregulated expression of NF-Y target genes have poor prognosis in multiple cancers (4, 16) . Using global gene expression profiles, the involvement of NF-Y in cancer-associated pathways has been recently reported across human cancers (17) .
Apoptosis and proliferation are intimately coupled. A tight linkage between cell-cycle regulation and apoptosis has been shown for c-myc, E2F1, and cyclins. These genes may induce cell proliferation, cell-cycle arrest, or cell death, with the different outcomes depending on variables such as cell type, cellular environment, and genetic background (18) . Intriguingly, many of these genes are NF-Y transcriptional targets (4, 5, 7, 15, (19) (20) (21) (22) .
Multiple signaling pathways activated by cellular stress converge on the wtp53 tumor suppressor whose activation can lead to growth arrest or programmed cell death (23) . Activation of p53 can result not only from physical and chemical stresses but also from oncogene imbalance. For example, expression of c-myc leads to p53-dependent apoptosis (24) through a mechanism largely dependent on E2F1 (25) , a member of the E2F family that controls expression of genes important for cell-cycle progression and apoptosis (26) . Ectopic expression of E2F1 induces p53-dependent apoptosis both in tissue culture (27) (28) (29) and in mouse models (30, 31) , and a similar role for endogenous E2F1 is evidenced by the defect in apoptosis in E2F1-deficient mice (32) . Different mechanisms have been proposed for the ability of E2F1 to cause apoptosis through both p53-dependent and -independent pathways. In the first case, p53 is phosphorylated at residues that are also phosphorylated in response to DNA damage (33) (34) (35) (36) .
The ability of NF-Y to control, like E2F1, the expression of many genes important for cell-cycle progression prompted us to investigate whether deregulation of NF-Y transcriptional activity could trigger a tumor suppressor network capable of inducing cell death. We overexpressed the regulatory subunit of the trimer, NF-YA, in mouse embryonic fibroblasts (MEF) and in human cells and showed that unrestrained NF-Y activity promotes apoptosis depending on E2F1 induction and wtp53 activation. Our results demonstrate that NF-Y activates a tumor suppressor network that functions at multiple levels to efficiently induce cell death in wtp53-expressing cells.
Materials and Methods

Cells lines
Mouse embryonic fibroblasts were isolated from 13.5-dayold embryos as described previously (36) . MEFs derived from p53 À/À mouse embryos (gift from Silvia Soddu), or from E2F1 À/À and p73 À/À mouse (gift from Massimo Levrero) and human breast carcinoma SKBR3 (mut p53-175H) were cultured in DMEM supplemented with 10% FBS (GIBCO BRL), 2 mmol/L of L-glutamine (Life Technologies Inc.), 100 U/mL of penicillin, and 100 mg/mL of streptomycin (Life Technologies Inc.). Primary breast epithelial cells MCF10A were cultured in Ham's F-12 medium with 5% horse serum, 0.5 mg/mL of hydrocortisone, 10 mg/mL of insulin, and 20 ng/mL of epidermal growth factor.
Viral vectors and infection
The adenoviral vectors used for infections were as follows: Ad-NF-YA, Ad-control (Ad-GFP; ref. 37) , and Ad-E2F1. Cells exponentially growing on plates were infected in DMEM without serum for 1 hour at 37 C at a multiplicity of infection of 400 pfu per cell. Following infection, DMEM with 10% FBS was added and the cells were incubated at 37 C and analyzed at the indicated time points.
Plasmids and transfections
Plasmids used in transfections were as follows: NF-YA, NF-YB, dnNF-YA, empty vector (Poly II; ref. 1), E1A (E1A12S), HaRas, and pBABE-PURO (vector bearing puromycin resistance gene). Cells were transfected with Fugene6 (Roche) following the manufacturer's instructions. Transfection efficiency was normalized through b-galactosidase activity and protein concentrations.
Colony formation assay
For colony-forming assays cells were plated in 60-mm dish and transfected with the indicated vectors. After 48 hours, puromycin (1 mg/mL) was added for selection for 2 weeks. Surviving colonies were stained with crystal violet, photographed, and colony number counted under a microscope.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as previously described (7) . The following antibodies were used: anti-H4ac-Pan, (Upstate), anti-H3K9ac (Abcam), anti-H3tri-mk9 (Abcam), anti-H4tri-m-k20 (Abcam), and anti-NF-YA (Rockland). PCR analysis was performed with HOT-MASTER Taq (Eppendorf). Primer sequences specific for analysis were as follows: mouse E2F1 promoter-for 5 0 -gacagtgaacgctctcaggc, Rev 5 0 -ccgaacgcctcctccattgg; human E2F1 promoter; for 5 0 -ggctacaggttgagggtcacg, Rev 5 0 -gagcgccgccacaattggct.
RNA extraction and real-time-PCR
Total RNA was extracted using the Trizol reagent (Gibco BRL) following the manufacturer's instructions. The firststrand cDNA was synthesized according to the instructions for the M-MLV RT kit (Invitrogen). RT-PCR analysis was performed with HOT-MASTER Taq (Eppendorf), using 2 mL of cDNA reaction. The primers were as follows: E2F1-for 5 0 -TCTGTACCACACAGCTGCAA, Rev 5 0 -GCACAGGAAAACAT-CAATGG; aldolase, for 5 0 -TGG ATG GGC TGT CTG AAC GCT GT, Rev 5 0 -AGT GAC AGC AGG GGG CAC TGT. Densitometric analysis was performed using Scion-image software.
Quantitative PCR
Quantitative PCR (qPCR) was performed using SYBR Green (Applied Biosystems) on an ABI Prism 7500 apparatus (Applied Biosystems) in 2 independent experiments in triplicate. The comparative threshold (DCt) method (7) was used. Primer sequences were as follows: mouse E2F1 promoter-For 5 0 -gggtggagaccacaggttga, Rev 5 0 -ctggcgaagcgaacaaactt; mouse E2F1 MRNA-For 5 0 -cacagctgcaactgctttcg, Rev 5 0 -aaggtcctggcaggtcacatag.
Growth and lethality curves
Cells were harvested at different time points after infection or transfection and cell number was determined in duplicate, with a Thomas hemocytometer. Lethality was determined by counting the number of cells stained with trypan blue.
FACS cell-cycle analysis
Cells were harvested, washed in PBS, and fixed in MetOH: acetic acid solution (4:1) for 60 minutes at þ4 C. Cells were then incubated in 500 mL of staining solution (50 mg/mL of propidium iodide, 50 mg/mL of RNAase, 0.1% Triton X-100 in PBS 1Â) for 1 hour at 4 C and analyzed by flow cytometry.
Western blotting
Cells were harvested into 1Â RIPA buffer (150 mmol/L of NaCl, 1% TritonX-100, 0.25% sodium deoxycholate, 0.1% SDS, 50 mmol/L of Tris/HCl, pH ¼ 8.0, 20 mmol/L of EDTA) supplemented with 1Â protease and phosphatase inhibitor cocktail (Sigma-Aldrich), 1 mmol/L of PMSF (SigmaAldrich), 50 mmol/L of sodium fluoride (Sigma-Chemical Co.), and 50 mmol/L of dithiothreitol (Bio-Rad Laboratories Inc.). Lysates were resolved onto SDS-PAGE. For p-Erk1/2 detection, lysates were boiled at 65 C. After blotting, filters were immune reacted with anti-NF-YA (Rockland), anti-p53 (DOI, 5), anti-pS15-p53 and pS18 mouse (Cell Signaling), anti-pS139-H2A.X (Upstate), anti-pS1981-ATM (Rockland), anti-cdk1 (Santa Cruz), anti-cycA (Santa Cruz), anti-E2F1 (Santa Cruz), and (Santa Cruz), anti-Erk1/2 (Cell Signaling), anti-pErk1/2 (Cell Signaling), anti-HSP70 (StressGen), anti-a-actin (Calbiochem), anti-actin (Calbiochem), anticaspase 3 (Cell Signaling), and anti-Parp (BD Biosciences). Signals were detected by ECL detection reagents (Amersham Biosciences).
Statistical analysis
All experiments were performed in triplicate. Numerical data were reported as means AE SD. P values were determined using t test (GraphPad software). A 95% confidence interval (P < 0.05) was considered significant.
Results
Unrestricted NF-Y activity inhibits clonogenicity of mouse embryo fibroblasts
To examine the effect of unrestricted NF-Y activity, MEFs were transfected with a plasmid encoding NF-YA or empty vector, along with a vector bearing puromycin resistance. Puromycin selection was applied for 48 hours, and colonies were stained and counted 2 weeks later. We found that NF-YA overexpression led to more than 80% reduction of colony formation. This reduction was NF-YA specific, as ectopic expression of NF-YB had no effect (Fig. 1A) . This is in good agreement with the notion that the NF-YA is the regulatory subunit of the complex. As a control we used a dominantnegative NF-YA protein (dnNF-YA) carrying a mutant DNAbinding domain that interacts with the YB/YC dimer but does not bind DNA. When overexpressed, this mutant acts as a competitive inhibitor of interaction between wild-type NF-YA and the YB/YC dimer, forming an inactive complex in terms of DNA binding activity. It has been previously described that the expression of this protein results in retardation of cell growth (12) . As expected, overexpression of the mutant protein in MEFs resulted in the inhibition of colony formation. Taken together, these results strongly indicate that unbalanced NF-Y transcriptional activity leads to defects in cell proliferation (Fig. 1A) .
To assess whether NF-Y could alter proliferation also of transformed MEFs, we cotransfected MEFs with the Ha-Ras and E1A oncoproteins. As expected, the cotransfection yielded numerous transformed foci as compared with Ha-Ras or E1A alone (Supplementary Figure S1 ; ref. 37 ). Ha-Ras/E1A-transformed foci were harvested, amplified, and used in colony formation assays. Interestingly, overexpression of NF-YA in these cells still resulted in the inhibition of colony formation (Fig. 1B) . Taken together, these results demonstrate that unrestricted NF-Y activity, either alone or in combination with oncogenes, inhibits colony formation.
Unrestricted NF-Y activity inhibits cell growth-inducing apoptosis
To characterize the decrease in clonogenicity of NF-YAoverexpressing cells, MEFs were transduced with an adenoviral vector encoding NF-YA (Ad-NF-YA) or an empty vector as negative control (Ad-control). Figure 2A shows that NF-YA expression reduced MEFs proliferation. Indeed, while control cells more than doubled in number by 72 hours after infection, NF-YA transduced cells did not. We used FACS analysis to determine whether the reduced cell growth reflected an aberrant cell-cycle progression. As shown in Fig. 2B , NF-YA overexpression induced a small but reproducible increase in the G 2 / M cell population and a corresponding decrease of G 1 cells at 24 and 48 hours after infection. Next, we asked whether the reduction of MEF proliferation reflected augmented cell death. ( Fig. 2C) , suggesting induction of apoptosis. To test this hypothesis, we investigated whether overexpression of NF-YA increases PARP and caspase 3 cleavage. Figure 2D shows a reduction in the full-length form of PARP-1 and an increase of the cleaved caspase 3 in Ad-NF-YA-infected cells.
E2F1 is induced by unrestricted NF-Y activity and is necessary for NF-Y-mediated inhibition of colony formation
E2F1 has been shown to regulate both cell-cycle progression and cell death when overexpressed. Moreover, both murine and human E2F1 promoters contain 3 CCAAT boxes shown to be bound by NF-Y (38-40). These considerations prompted us to assay whether the NF-Y effects on apoptosis were E2F1 mediated.
To determine whether NF-YA overexpression could directly induce E2F1 expression, MEFs were infected with either Ad-NF-YA or Ad-control and E2F1 expression was measured by Western blotting. Figure 3A shows that the E2F1 protein level was increased in NF-YA overexpressing cells. Next, we asked whether the downmodulation of NF-Y activity diminished E2F1 protein expression. Supplementary Figure S3 shows that silencing of NF-YA by siRNA induced a timedependent downmodulation of endogenous E2F1 expression.
To investigate whether NF-Y modulates E2F1 expression at the transcriptional level, we analyzed the amount of E2F1 mRNA by quantitative real-time PCR (qRT-PCR) and RT-PCR. E2F1 mRNA was upregulated as early as 8 hours after Ad-NF-YA infection (Fig. 3B) . To further support the role of NF-Y on E2F1 transcription, we investigated whether NF-Y modulated the chromatin structure of the E2F1 promoter by ChIP experiments in Ad-NFYA and Adcontrol infected cells with anti-NF-YA, -H3K9ac, -H4ac, -H3K9me3, and -H4K20me3 antibodies. H3K9ac and H4ac are well-known markers of open chromatin structure, whereas H3K9me3 and H4K20me3 mark heterochromatin (41) (42) (43) . As expected, NF-Y was bound to the E2F1 promoter and overexpression of NF-YA led to a significant increase in this binding (Fig. 3C) . Of note, this increase correlated with a significant enrichment in the acetylation density of H3K9 and, to a lesser extent, of H4. The acetylation density of histones associated with closed chromatin conformation was very low before and after NF-YA overexpression. NF-Y binding to the E2F1 promoter occurs also in human cells, as demonstrated by ChIP experiments on several human cell lines (Supplementary Figure S4) .
We further asked whether E2F1 mediates the apoptosis induced by NF-YA overexpression. MEFs derived from E2F1 À/À mice were transfected with a plasmid encoding NF-YA or vector alone, and colony formation was assayed. Figure 3D shows that NF-YA failed to decrease the efficiency of colony formation in the absence of E2F1 expression. 
NF-YA induces p53 activation via E2F1
E2F1 has been shown to induce apoptosis via multiple pathways, some of which involve stabilization and activation of the tumor suppressor p53 (44) . To assess the role of p53 in NF-Y-dependent apoptosis, p53 À/À MEFs were used. Figure 4A shows that the decrease in colony formation induced by NF-YA is p53 dependent because no difference in colony formation efficiency was found in p53 (Fig. 4B) . Of note, when the ability of NF-YA to decrease colony formation was assayed in p73
MEFs, results indistinguishable from those in wild-type MEF cells were obtained (Fig. 4C) . Similar levels of NF-YA protein were expressed in p73 À/À and p53 À/À MEFs (Fig. 4D) , excluding the possibility that the different biological effects were due to different NF-YA amounts and demonstrating a specific p53 role in transducing NF-Y signaling.
These results prompted us to analyze whether unrestricted NF-Y activity triggered p53 activation. Both p53 stabilization and phosphorylation at serine-18 (Ser18; Ser15 in humans) represent crucial steps in p53 activation mediated by oncogenic imbalance (45) . We found that NF-YA overexpression induced a small but reproducible increase in p53 protein level. Interestingly, it also increased p53Ser18 phosphorylation (Fig. 5A) . Because E2F1 is necessary for NF-Y-dependent apoptosis, we assessed whether p53Ser18 phosphorylation was mediated by E2F1. Figure 5B shows that NF-YA overexpression did not trigger p53Ser18 phosphorylation in Figure S5) . Furthermore, NF-YA overexpression did not trigger p53Ser15 phosphorylation in human primary breast epithelial cells (MCF10A) interfered for E2F1 (Fig. 5C ) and failed to induce apoptosis in these cells unlike the case with wild-type MCF10A cells (Fig. 5D) . One of the E2F1 targets is p14ARF (p19ARF in rodents). However, in several systems, ARF function seems to be independent from that of E2F1-induced p53 activation and apoptosis (44) . Intriguingly, ARF expression was not modulated by NF-YA (data not shown), indicating that NF-Y-induced activation of p53 can be mediated by mechanisms that are ARF independent. It has been reported that the ataxia telangiectasia mutated (ATM) kinase is activated and directly phosphorylates p53 on Ser15 in response to DNA damage and/or oncogenic stress such as Myc overexpression (46) . We asked, therefore, whether unrestricted NF-Y activity triggered ATM activation. As shown in Supplementary Figure S6 , NF-YA overexpression leads to the phosphorylation of ATMSer1981, a marker of ATM activation (47) as well of the ATM substrate histone H2A.X (on Ser139, g-H2A.X), suggesting that unrestricted NF-Y activity, activating ATM, can mimic DNA damage.
Taken together, these results demonstrate that unrestricted NF-Y activity utilizes, in both murine and human cells, the E2F1 pathway to trigger p53 activation and suggest that it induces apoptosis via this mechanism.
Unrestricted NF-Y activity inhibits cell proliferation in human cells expressing wtp53
We tested the effect of unrestricted NF-Y activity on colony formation in human MCF10A cells and lung embryonic fibroblast (IMR90) expressing endogenous wtp53 (Fig. 6A) . The results show that NF-YA overexpression induced a 60% and 55.82% decrease in colony formation, respectively. Interestingly, colony formation also was inhibited in human tumor cells (HCT116) expressing wtp53 but not in the same cells lacking p53 (HCT116 p53 À/À ), indicating that unrestricted NF-Y activity induces apoptosis through wtp53 regardless of the transformed status of the cells.
Next, we measured cell proliferation and viability by trypan blue exclusion. As observed in MEFs, NF-YA overexpression reduced proliferation of MCF10A cells that express wtp53 (Fig. 6B ). In addition, as already shown in Fig. 5D , the percentage of dead cells increased 24 hours posttransfection (Supplementary Figure S7) . Conversely, NF-YA overexpression increased the proliferation rate of SKBR3 human breast cancer cells (SKBR3) harboring endogenous mutant p53His175 (Fig. 6C ) but had no effect on cell death in these cells (Supplementary Figure S4) . As shown in Fig. 6D , in MCF10A cells, NF-YA overexpression correlated with p53 accumulation and activation. Thus, in human cells too, unrestricted NF-Y activity increased E2F1 protein levels, and, as expected, cyclin A and cdk1 expression and Erk phosphorylation, all markers of active proliferation, were decreased. No effect on p53 and E2F1 levels was observed in SKBR3 cells, and cyclin A and cdk1 expression and Erk phosphorylation were induced in agreement with the increased proliferation rate shown in Fig. 6C .
These results further support the hypothesis that unrestricted NF-Y activity leads to apoptosis in a wtp53-dependent manner. Moreover, they also suggest that unrestricted NF-Y activity increases cell proliferation in cells expressing mutant p53.
Discussion
Over the past 10 years, much effort has been made toward establishing the role of NF-Y in controlling cell proliferation in vivo (4, 6, 7, (12) (13) (14) . Here, we examined the effect of unrestricted NF-Y activity on proliferation of primary cells. We show that sustained activity of NF-Y can regulate pathways involved in apoptosis and we describe a novel linkage between NF-Y, E2F1, and p53 that could help to understand the fine cross talk between cell cycle and apoptosis. The relevant new findings are that unrestricted NF-Y activity (a) inhibits cell proliferation by inducing apoptosis and (b) leads to an E2F1-and wtp53-dependent apoptosis in both mouse and human cells.
The evidence that deregulated NF-Y expression induces apoptosis by activating an E2F1-dependent p53 pathway links loss of proliferation control to an apoptotic pathway, with some similarities to that induced by oncogenes. The role of E2F1 as mediator of the NF-Y effect is clearly demonstrated by the fact that unrestricted NF-Y activity does not induce apoptosis in E2F1 À/À cells. Furthermore, the increase in E2F1 mRNA by unrestricted NF-Y activity and the NF-Ydependent enrichment on the E2F1 promoter of hyperacetylated histones H3 and H4 demonstrate that E2F1 is more actively transcribed after NFY overexpression. Our results support a model in which excessive E2F1, induced by NF-Y, sensitizes cells to apoptosis. Unrestricted E2F1 activity induces p53-dependent apoptosis in both cell cultures and mouse models (25) (26) (27) (28) (29) (30) (31) (32) , and our data reveal a specific role for p53 in transducing NF-Y apoptotic signaling. It is, therefore, not surprising that p53 is also mutated or deleted in a large number of human cancers (45) . Our results further suggest that deregulated NF-Y expression induces apoptosis by activating an E2F1-dependent p53 pathway known not to involve p19ARF (44) . This is in agreement with the ability of ectopically expressed ARF to target E2F1 for degradation (48) . Furthermore, our evidence that unrestricted NF-Y activity induces ATM, 
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which is known to phosphorylate and thus activate E2F1, strongly suggests that NF-Y induces p53-dependent apoptosis through this kinase. On the basis of our results from NF-YA overexpression, we speculate that the amount of this protein can dictate the cell decision between division and death. We have recently shown that a posttranslational molecular mechanism tightly regulates the transcriptional activity of NF-Y controlling the stability of NF-YA, the regulatory subunit of the complex (10) . NF-YA is degraded by ubiquitin-mediated proteolysis, and this could be one mechanism evolved by cells to tightly regulate NF-Y activity, failure of which would compromise cell survival and/or homeostasis. NF-Y is apparently not overexpressed in tumor cells, although its posttranslational regulation, occurring in normal cells, seems to be lost in transformed cells expressing mutant p53, leading to its constitutive expression (Manni et al., manuscript in preparation). In agreement with this, we have shown here that unrestricted NF-Y activity does not lead to apoptosis but to increased proliferation in mutant p53 expressing cells.
It is possible that the ability of NF-Y to drive apoptosis is distinct from its ability to drive cell division. However, this issue cannot be directly addressed until NF-Y target genes essential for apoptosis have been clearly identified. The factors that determine the decisions of inducing either cell division or cell death need to be further investigated. 
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